Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
1996 1
1997 1
1998 1
1999 2
2001 1
2002 1
2003 1
2004 3
2005 1
2006 1
2007 1
2008 2
2010 2
2011 1
2013 1
2018 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort.
England JT, McNamara CJ, Kennedy JA, Capo-Chichi JM, Huang J, Arruda A, Nye T, Cheung V, Claudio JO, Maze D, Sibai H, Tierens A, Tsui H, Bankar A, Xu W, Stockley T, Gupta V. England JT, et al. Among authors: claudio jo. Leukemia. 2022 Jun;36(6):1689-1692. doi: 10.1038/s41375-022-01544-x. Epub 2022 Mar 26. Leukemia. 2022. PMID: 35347238 Free PMC article. No abstract available.
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.
McNamara CJ, Panzarella T, Kennedy JA, Arruda A, Claudio JO, Daher-Reyes G, Ho J, Siddiq N, Devlin R, Tsui H, Su J, Stockley T, Sukhai M, Kanwar N, Chan S, Maze D, Schimmer A, Schuh A, Sibai H, Viswabandya A, Yee K, Minden MD, Kamel-Reid S, Gupta V. McNamara CJ, et al. Among authors: claudio jo. Blood Adv. 2018 Oct 23;2(20):2658-2671. doi: 10.1182/bloodadvances.2018021469. Blood Adv. 2018. PMID: 30327374 Free PMC article.
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.
Puckrin R, Atenafu EG, Claudio JO, Chan S, Gupta V, Maze D, McNamara C, Murphy T, Shuh AC, Yee K, Sibai H, Minden MD, Wei C, Stockley T, Kamel-Reid S, Schimmer AD. Puckrin R, et al. Among authors: claudio jo. Haematologica. 2021 Jan 1;106(1):56-63. doi: 10.3324/haematol.2019.235721. Haematologica. 2021. PMID: 31896684 Free PMC article.
A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles.
Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, Barr SG, Zummer M; GenES Investigators; Fortin PR, Wither J, Rioux JD. Budarf ML, et al. Among authors: claudio jo. Genes Immun. 2011 Jan;12(1):51-8. doi: 10.1038/gene.2010.47. Epub 2010 Oct 21. Genes Immun. 2011. PMID: 20962850
Expression and mutation status of candidate kinases in multiple myeloma.
Claudio JO, Zhan F, Zhuang L, Khaja R, Zhu YX, Sivananthan K, Trudel S, Masih-Khan E, Fonseca R, Bergsagel PL, Scherer SW, Shaughnessy J, Stewart AK. Claudio JO, et al. Leukemia. 2007 May;21(5):1124-7. doi: 10.1038/sj.leu.2404612. Epub 2007 Mar 8. Leukemia. 2007. PMID: 17344920 No abstract available.
26 results